Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Related FB
Why Google Cloud Will Fail
S&P 500 Index Futures Trading Lower Daily Round Up 11/27/15: UVE, WHF, ARES, KYN (Seeking Alpha)
Related BMY
Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma
Pamela Anderson And Hepatitis C: Which Drug Makers Are Working On A Cure?
FDA declines expanded approval for Bristol-Myers oncology drug (Seeking Alpha)

Analysts at BMO Capital upgraded Facebook (NASDAQ: FB) from “underperform” to “outperform.” Facebook's stock closed at $25.91 on Friday. Facebook had $10.45 billion in total cash for the latest quarter.

Atlantic Equities upgraded Bristol-Myers Squibb Company (NYSE: BMY) from “underweight” to “neutral.” Bristol-Myers' shares closed at $32.46 on Friday. Bristol-Myers' PEG ratio is 6.25.

Analysts at Needham upgraded PMFG (NASDAQ: PMFG) from “hold” to “buy.” PMFG's shares closed at $8.60 on Friday. PMFG's trailing-twelve-month revenue is $139.21 million.

Latest Ratings for FB

Nov 2015Argus ResearchMaintainsBuy
Nov 2015Credit SuisseMaintainsOutperform
Nov 2015Morgan StanleyMaintainsOverweight

View More Analyst Ratings for FB
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (BMY + FB)

View Comments and Join the Discussion!

Get Benzinga's Newsletters